No Licence Renewal For Blood Centres Sans Hospital

Dehradun: All blood centres operating outside of hospitals in Uttarakhand will no longer be eligible for licence renewal, a circular issued on Saturday by the Uttarakhand Food and Drug Authority (FDA) said.

Currently, 82 blood centres are operational in the state, and this directive is expected to impact 30-35 of them, a source in the department said. However, centres run by organisations like Indian Medical Association (IMA) or those under Red Cross will not be affected, as they are classified as charity organisations, according to officials.

Existing centres with a five-year licence will not have to establish a hospital, but once the licences expire, they will not be renewed unless they have moved into hospital premises.

Tajber Singh, additional commissioner, state Food and Drug Administration, said, “Affiliation with any hospital won’t help. Blood centres must be within hospital premises, to ensure that patients in need of blood and plasma receive priority. It also promotes strict preservation of blood as per protocols.”

The move is expected to curb high prices charged by private blood banks during crises and to address issues of incorrect blood transfusions by promoting proper testing and storage of blood.

Related Posts

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations